Sam Williams - Observer

Sam has 20 years' experience in the biotechnology industry, both as a top-ranked equity analyst in the City and, subsequently, as an entrepreneur and chief executive. He is CEO of Istesso Limited, a London-based drug discovery company, Non-Executive Chairman of C4X Discovery Holdings plc and Head of Biotech at IP Group plc. He holds a PhD in molecular biology from Cambridge and a degree in biology from Oxford.